Search

Jurgen L Venitz

from Richmond, VA
Age ~68
Get Report
Also known as:
Juergen Venitz
Phone and address:
222 Brook Run Dr, Richmond, VA 23233
(804) 784-8055
Related to:
Linda R Miller, 69Maynard J Miller, 90Hallie H SwinsonHeather E Swinson, 41Pamela S Venitz, 70Harry H Swinson, 95
Connected to:
Marina V Venizelos, 43Peter N Venizelos, 36Akil Venjara, 72Michael T Venjohn, 55Devi D Venkadesan, 27Krishna Venkanna, 71Aishwarya Venkataraman, 37Anuradha Venkat, 55Archana Venkataramanan, 40Arun Venkatadri, 42

Jurgen Venitz Phones & Addresses

  • 222 Brook Run Dr, Richmond, VA 23233 (804) 784-8055
  • 2304 Brookwater Dr, Richmond, VA 23233 (804) 754-0282
  • 1510 Split Oak Ln, Richmond, VA 23229 (804) 673-9232
  • 7705 Sunderland Rd, Richmond, VA 23229

Work

Company: Virginia commonwealth university May 2012 Position: Professor, dept. of pharmaceutics

Education

School / High School: University of Florida 1985 to 1987 Specialities: Postdoctoral Fellow (E.R. Garrett)

Skills

Pharmacology • Pharmacokinetics • Clinical Research • Clinical Trials • Drug Discovery • Clinical Pharmacology • Pharmacodynamics • Clinical Development • Life Sciences • Research • Pharmaceutical Industry • Neuroscience • Science • Drug Development • Translational Medicine • Molecular Biology • In Vivo • Pharmaceutics • Lifesciences • Immunology • Drug Metabolism • Oncology • Cancer • Translational Research • In Vitro • Statistics • Medical Writing • Physiology • Biomarkers • Data Analysis • Clinical Study Design • Toxicology • Biostatistics • Hplc • R&D • Fda • Pharmaceutical Research • Regulatory Submissions • Ind • Medical Research • Metabolism • Regulatory Affairs • Biopharmaceuticals • Clinical • Pharmaceuticals • Study Design

Emails

v***[email protected]

Industries

Higher Education

Resumes

Resumes

Jurgen Venitz Photo 1

Board Member

View page
Location:
Richmond, VA
Industry:
Higher Education
Work:
Virginia Commonwealth University since May 2012
Professor, Dept. of Pharmaceutics
Myasthenia Gravis Foundation of America, Inc since 2010
Board Member
Goodwyn IRB - Cincinnati Area since Jan 2000
Alternate Member
Virginia Commonwealth University - Richmond, Virginia Area Jan 1988 - May 2012
Associate Professor
Goodwyn IRB 2000 - 2011
Alternate Member
Education:
University of Florida 1985 - 1987
Universitaet des Saarlandes 1976 - 1985
Ph.D., Physiology Universitaet des Saarlandes 1974 - 1981
MD
Skills:
Pharmacology
Pharmacokinetics
Clinical Research
Clinical Trials
Drug Discovery
Clinical Pharmacology
Pharmacodynamics
Clinical Development
Life Sciences
Research
Pharmaceutical Industry
Neuroscience
Science
Drug Development
Translational Medicine
Molecular Biology
In Vivo
Pharmaceutics
Lifesciences
Immunology
Drug Metabolism
Oncology
Cancer
Translational Research
In Vitro
Statistics
Medical Writing
Physiology
Biomarkers
Data Analysis
Clinical Study Design
Toxicology
Biostatistics
Hplc
R&D
Fda
Pharmaceutical Research
Regulatory Submissions
Ind
Medical Research
Metabolism
Regulatory Affairs
Biopharmaceuticals
Clinical
Pharmaceuticals
Study Design

Publications

Us Patents

Ester Nitrates Derivatives Of Aromatic Aldehydes With Multiple Pharmalogic Properties To Treat Sickle Cell Disease

View page
US Patent:
20210053931, Feb 25, 2021
Filed:
Nov 3, 2020
Appl. No.:
17/088063
Inventors:
- Richmond VA, US
Yan Zhang - Glen Allen VA, US
Jurgen Venitz - Richmond VA, US
Tanvi Deshpande - Somerville MA, US
International Classification:
C07D 307/58
C07D 213/30
Abstract:
The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.

Aromatic Aldehydes With Sustained And Enhanced In Vitro And In Vivo Pharmacologic Activity To Treat Sickle Cell Disease

View page
US Patent:
20210002225, Jan 7, 2021
Filed:
Mar 18, 2019
Appl. No.:
16/982745
Inventors:
- Richmond VA, US
- Philadelphia PA, US
Piyusha Pradeep PARAGE - Richmond VA, US
Guoyan XU - Henrico VA, US
Mohini GHATGE - Glen Allen VA, US
Jurgen VENITZ - Richmond VA, US
Osheiza ABDULMALIK - Wynnewood PA, US
International Classification:
C07D 213/80
C07D 213/79
C07D 401/04
C07D 409/04
A61K 9/00
A61P 7/00
Abstract:
Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are based on vanillin which is chemically modified to increase bioavailability and activity, e.g. so that the compounds bind to the F helix of hemoglobin (Hb) and prevent adhesion of red blood cells (RBCs).

Ester Nitrates Derivatives Of Aromatic Aldehydes With Multiple Pharmalogic Properties To Treat Sickle Cell Disease

View page
US Patent:
20200369638, Nov 26, 2020
Filed:
Aug 7, 2020
Appl. No.:
16/987609
Inventors:
- Richmond VA, US
Yan Zhang - Glen Allen VA, US
Jurgen Venitz - Richmond VA, US
Tanvi Deshpande - Somerville MA, US
International Classification:
C07D 307/58
C07D 213/30
Abstract:
The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.

Allosteric Hemoglobin Modifiers With Nitric Oxide Releasing Moiety

View page
US Patent:
20160326097, Nov 10, 2016
Filed:
Dec 22, 2014
Appl. No.:
15/107962
Inventors:
- Richmond VA, US
Richmond DANSO-DANQUAH - Richmond VA, US
Mohini GHATGE - Richmond VA, US
Jurgen VENITZ - Richmond VA, US
Martin MANGINO - Richmond VA, US
Kevin R. WARD - Richmond VA, US
Assignee:
VIRGINIA COMMONWEALTH UNIVERSITY - Richmond VA
International Classification:
C07C 235/38
A61K 33/00
A61K 45/06
A61K 31/216
C07C 245/24
A61K 31/655
Abstract:
Allosteric hemoglobin (Hb) modifiers of hemoglobin which contain nitric oxide (NO) moieties allowing for the release of NO in vivo. The compounds retain the oxygen delivery capability of the allosteric hemoglobin modifier to bind Hb and enhance Hb's ability to deliver oxygen to cells and tissues, and also release NO from the NO moiety. Methods of delivering oxygen and/or NO to cells and tissues are also provided.

Ester Nitrates Derivatives Of Aromatic Aldehydes With Multiple Pharmalogic Properties To Treat Sickle Cell Disease

View page
US Patent:
20160221978, Aug 4, 2016
Filed:
Aug 21, 2014
Appl. No.:
14/913180
Inventors:
- Richmond VA, US
Jurgen VENITZ - Richmond VA, US
Richmond DANSO-DANQUAH - Henrico VA, US
Tanvi DESPANDE - Baltimore MD, US
Yan ZHANG - Glen Allen VA, US
International Classification:
C07D 307/58
C07D 213/30
Abstract:
The invention provides new aromatic aldehyde compounds that have greater potency in increasing the affinity of Hb for oxygen, greater potency for preventing sickling, and additional pharmacologic properties that ameliorate other symptoms of SCD. The invention further provides methods for treating SCD by providing a subject having SCD with a compound according to the invention.
Control profile
Jurgen L Venitz from Richmond, VA, age ~68 Get Report